TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1809806
国際登録日2024-06-03
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Biological preparations for gene therapy; adeno-associated virus (aav) gene therapy preparations and pharmaceuticals; biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics.,Pharmaceutical research and development in the field of gene therapy; pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of rna-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery.,Medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, tauopathies, synucleinopathies, and neurodegenerative disease.
基礎出願番号90879826
基礎出願日2021-08-12
基礎出願国US
出願人Voyager Therapeutics, Inc.
OCRテキストVOYAGEK
OCRテキスト2VOYAGER
OCRについて
この商標をJ-PlatPatで参照する

関連商標

KAMUT ENTERPRISES OF EUROPE, BV
KAMUT BRANDWHEAT
5か月前
Beijing Compont Medical Devices Co., Ltd.
compont
24日前
NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
3か月前
DePuy Ireland Unlimited Company
SMARTSET
10日前
ZEALAND PHARMA A/S
2か月前
DAM Group UK International Limited
8 .***Dr.Frank's WeightLossClinic
3か月前
GlaxoSmithKline Biologicals S.A.
EXFLUNA
17日前
SOP INDUSTRIES SDN BHD
Avant health
3か月前
Novo Nordisk A/S
Zembrilio
7か月前
Aston Group Worldwide Ltd
INESSA
2か月前
GlaxoSmithKline Biologicals S.A.
RIXFLUGO
17日前
Novo Nordisk A/S
Zilconyc
7か月前
Biohaven Therapeutics Ltd.
REJUTRIA
2か月前
Alcon Inc.
TRIPTYR
8か月前
Alcon Inc.
TRYPTYR
8か月前
Huang, Ke
1か月前
OLIVIT Sp. z o.o.
osavi
6か月前
LESAFFRE ET COMPAGNIE
2か月前
Huang, Ke
1か月前
Made By Brave Limited
2か月前
Biohaven Therapeutics Ltd.
2か月前
Made By Brave Limited
ANCIENT+BRAVE
2か月前
Sequrna AB
SEQURNA
4か月前
DR.ANKERSTJERNE AS
DR.STINE ANKERSTJERNE
5か月前
NUTRAVALIA
LUXEOL
5か月前
MAFRA GROUP S.r.l.
MANIAC LINE
2か月前
Harbin Fuerjia Technology Co., Ltd.
Voolga
2か月前
Harrow IP, LLC
2か月前
EXELTIS HEALTHCARE, S.L.
2か月前
Merck Sharp & Dohme B.V.
CYPTAVOS
7か月前
Merck Sharp & Dohme B.V.
CYPZURAS
7か月前
MedinCell S.A.
3か月前
Merck Sharp & Dohme B.V.
PRIZULIO
7か月前
NOVARTIS AG
4か月前
ZEALAND PHARMA A/S
3か月前
Dyne Therapeutics, Inc.
2か月前
続きを見る